Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation

SIMPLE SUMMARY: Upfront genetics/cytogenetics and minimal measurable disease (MRD) are becoming relevant biomarkers in the process of post-remission transplant allocation in AML. However, until recently the transplantation choice relied on the availability of a fully matched familiar donor, whereas...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Buccisano, Francesco, Palmieri, Raffaele, Piciocchi, Alfonso, Maurillo, Luca, Del Principe, Maria Ilaria, Paterno, Giovangiacinto, Soddu, Stefano, Cerretti, Raffaella, De Angelis, Gottardo, Mariotti, Benedetta, Irno Consalvo, Maria Antonietta, Conti, Consuelo, Fraboni, Daniela, Divona, Mariadomenica, Ottone, Tiziana, Lavorgna, Serena, Panetta, Paola, Voso, Maria Teresa, Arcese, William, Venditti, Adriano
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959451/
https://ncbi.nlm.nih.gov/pubmed/33802502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051083
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items